⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20523340 | 0.95 | — | — | |
| SCHEMBL1862875 | 0.82 | — | — | |
| SCHEMBL11148191 | 0.82 | — | — | |
| SCHEMBL2593848 | 0.78 | — | — | |
| SCHEMBL256063 | 0.78 | — | — | |
| SCHEMBL10188210 | 0.73 | — | — | |
| SCHEMBL20523142 | 0.73 | HIF1A (0.31) | — | |
| SCHEMBL20523246 | 0.73 | — | — | |
| SCHEMBL64228 | 0.72 | — | — | |
| Ammonia Solution, Strong SCHEMBL901105 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 590 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE43858-E1 | Substituted cycloalkene derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2012-12-11 | — | — | US | claimed |
| US-7935835-B2 | Substituted cycloalkene derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2011-05-03 | — | — | US | claimed |
| US-20090233952-A1 | SUBSTITUTED CYCLOALKENE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2009-09-17 | — | — | US | claimed |
| EP-1625112-B1 | NOVEL COMPOUNDS FOR TREATMENT OF OBESITY | HIGH POINT PHARMACEUTICALS LLC (US) | 2009-07-22 | — | — | EP | claimed |
| EP-1935879-A1 | SUBSTITUTED CYCLOALKENE DERIVATIVE | Daiichi Sankyo Company, Limited (JP) | 2008-06-25 | — | — | EP | claimed |
| EP-0525629-A2 | 5-membered heterocycles, process for their preparation and medicaments containing them | Dr. Karl Thomae GmbH (DE) | 1993-02-03 | — | — | EP | claimed |
| WO-2024126453-A1 | NEW SUBSTITUTED INDOLE-2-CARBOXAMIDES AS PHGDH INHIBITORS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2024-06-20 | — | — | WO | disclosed |
| WO-2024089155-A1 | HETEROCYCLIC COMPOUNDS AS STING ANTAGONISTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2024-05-02 | — | — | WO | disclosed |
| WO-2023073641-A9 | ANTHELMINTIC PYRROLOPYRIDAZINE COMPOUNDS | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2024-02-29 | — | — | WO | disclosed |
| US-20240055662-A1 | NONAQUEOUS ELECTROLYTE ENERGY STORAGE DEVICE, ELECTRONIC DEVICE, AND AUTOMOBILE | GS YUASA INTERNATIONAL LTD. (JP) | 2024-02-15 | — | — | US | disclosed |
| US-20230374021-A1 | [1,3]DIAZINO[5,4-d]PYRIMIDINES AS HER2 INHIBITORS | BOEHRINGER INGELHEIM INT (DE) | 2023-11-23 | — | — | US | disclosed |
| US-20230374021-A1 | [1,3]DIAZINO[5,4-d]PYRIMIDINES AS HER2 INHIBITORS | BOEHRINGER INGELHEIM INT (DE) | 2023-11-23 | — | — | US | disclosed |
| US-11814380-B2 | Benzylamino substituted pyridopyrimidinones and derivatives as SOS1 inhibitors | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2023-11-14 | — | — | US | disclosed |
| US-20020009635-A1 | Novel materials for use as electrolytic solutes | MICHOT CHRISTOPHE (FR) | 2002-01-24 | — | — | US | disclosed |
| CN-1290408-A | Electrolytes containing mixed fluorocarbon/hydrocarbon imide and methide salts | MINNESOTA MINING & MFG (US) | 2001-04-04 | — | — | CN | disclosed |
| US-6063522-A | IMIDE OR METHIDE CONDUCTIVE SALTS OF GIVEN FORMULA HAVING MIXED FLUOROCHEMICAL AND HYDROCARBON GROUPS; RELATIVELY INEXPENSIVE SALTS EXHIBIT GOOD CONDUCTIVITY IN ELECTROLYTES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2000-05-16 | — | — | US | disclosed |
| EP-0980353-A1 | FLUORINATED SULPHONAMIDE AND SULPHONE DERIVATIVES | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 2000-02-23 | — | — | EP | disclosed |
| WO-1998050349-A1 | FLUORINATED SULPHONAMIDE AND SULPHONE DERIVATIVES | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1998-11-12 | — | — | WO | disclosed |
| US-5463071-A | Tetrazole derivatives; useful for inhibiting undesirable cell aggregation | DR. KARL THOMAE GMBH (DE) | 1995-10-31 | — | — | US | disclosed |
| EP-0525629-A2 | 5-membered heterocycles, process for their preparation and medicaments containing them | Dr. Karl Thomae GmbH (DE) | 1993-02-03 | — | — | EP | disclosed |